focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nano Regulatory News (ONT)

Share Price Information for Oxford Nano (ONT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 108.20
Bid: 108.20
Ask: 108.60
Change: -3.30 (-2.96%)
Spread: 0.40 (0.37%)
Open: 112.80
High: 112.80
Low: 107.00
Prev. Close: 111.50
ONT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Incentive Plan - Director/PDMR Shareholding

11 Nov 2022 16:30

RNS Number : 1960G
Oxford Nanopore Technologies plc
11 November 2022
 

11 November 2022

Oxford Nanopore Technologies plc (the "Company")

Share Incentive Plan ("SIP") PDMR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified by Solium Trustee (UK) Limited, the trustee of the SIP (the "SIP Trustee") that on 11 November 2022, it made an award of Partnership Shares (as defined in the SIP) of 56 ordinary shares of £0.0001 each ("Ordinary Shares") on behalf of Tim Cowper, a director of the Company and a Person Discharging Managerial Responsibilities ("PDMR") and 56 Ordinary Shares on behalf of Clive Brown, a director of the Company and a PDMR. The Ordinary Shares were purchased using each participating employee's gross salary at a price of £2.70 per Ordinary Share.

Under the SIP, the SIP Trustee will award each participating employee one Matching Share (as defined in the SIP) for each Ordinary Share purchased by the employee under the SIP. On 11 November 2022, the Company issued 56 Ordinary Shares to the SIP Trustee to hold on behalf of Tim Cowper to satisfy the Matching Shares awarded under the SIP to him on that date, and 56 Ordinary Shares to the SIP Trustee to hold on behalf of Clive Brown to satisfy the Matching Shares awarded under the SIP to him on that date.

Further details of the transactions referred to above by the SIP Trustee are set out below:

Name of PDMR

Number of Partnership Shares

Number of Matching Shares

Tim Cowper (Director)

56

56

Clive Brown (Director)

56

56

 

This announcement is made pursuant to the Company's obligations under Article 19(3) of the UK Market Abuse Regulation.

Tim Cowper - purchase of shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Timothy Cowper

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Purchase of Ordinary Shares under the SIP, held through the SIP Trustee.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£2.70

56

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

56 shares

£151.20

 

e)

Date of the transaction

11 November 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 

Tim Cowper - issue of new shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Timothy Cowper

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Grant of Matching Shares through an issue of Ordinary Shares under the SIP, held through the SIP Trustee

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

56

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

56 shares

Nil

e)

Date of the transaction

11 November 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

Clive Brown - purchase of shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Gavin Brown

2

Reason for the notification

a)

Position/status

Chief Technology Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Purchase of Ordinary Shares under the SIP, held through the SIP Trustee.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£2.70

56

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

56 shares

£151.20

e)

Date of the transaction

11 November 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

Clive Brown - issue of new shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Clive Gavin Brown

2

Reason for the notification

a)

Position/status

Chief Technology Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Grant of Matching Shares through an issue of Ordinary Shares under the SIP, held through the SIP Trustee

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

56

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

56 shares

Nil

e)

Date of the transaction

11 November 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

Enquiries:

Investors

ir@nanoporetech.com 

Media 

media@nanoporetech.com

oxfordnanoporetechnologies@tulchangroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAKFFFELAFFA
Date   Source Headline
3rd Oct 20225:00 pmRNSIssue of Equity and Total Voting Rights
29th Sep 20229:00 amRNSDirector/PDMR Shareholding
14th Sep 202211:00 amRNSDirector/PDMR Shareholding
13th Sep 20225:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
13th Sep 20227:00 amRNSInterim results for the period ended 30 June 2022
12th Sep 20224:30 pmRNSOxford Nanopore to present at upcoming conferences
1st Sep 20226:30 pmRNSIssue of Equity and Total Voting Rights
24th Aug 20227:00 amRNSNotice of Results
11th Aug 20224:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Aug 20225:30 pmRNSIssue of Equity and Total Voting Rights
12th Jul 20225:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
11th Jul 20227:00 amRNSSale and leaseback of headquarters building
1st Jul 20225:16 pmRNSIssue of Equity and Total Voting Rights
30th Jun 20227:15 amRNSDuncan Tatton-Brown appointed as Non-Exec Chair
23rd Jun 20224:30 pmRNSResult of AGM
13th Jun 20224:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Jun 20224:00 pmRNSIssue of Equity and Total Voting Rights
31st May 20226:30 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSONT releases Remora:most comprehensive methylation
20th May 20227:00 amRNSOxford Nanopore announces tech updates
19th May 20229:06 amRNSONT opens user conference, rich science programme
13th May 20227:00 amRNSONT chosen for comprehensive human genome program
11th May 20224:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
3rd May 20224:00 pmRNSIssue of Equity and Total Voting Rights
12th Apr 20226:15 pmRNSShare Incentive Plan - Director/PDMR Shareholding
12th Apr 20221:01 pmRNSDirector/PDMR Shareholding
12th Apr 20221:01 pmRNSDirector/PDMR Shareholding
12th Apr 20221:00 pmRNSDirector/PDMR Shareholding
12th Apr 20227:00 amRNSPublication of Annual Report and Notice of AGM
6th Apr 20221:00 pmRNSBlock listing Interim Review
5th Apr 202211:00 amRNSDirector/PDMR Shareholding
4th Apr 20222:00 pmRNSGenomics England expands Nanopore use in cancer
1st Apr 20225:00 pmRNSIssue of Equity and Total Voting Rights
1st Apr 20227:00 amRNSAgreement
30th Mar 20222:00 pmRNSONT shows new high-accuracy, high-output chemistry
24th Mar 20227:00 amRNSNanopore sequencing profiles TB: FIND evaluation
23rd Mar 20222:02 pmRNSOxford Nanopore releases Short Fragment Mode
22nd Mar 20227:00 amRNSPreliminary Results and Guidance Update
11th Mar 20225:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
10th Mar 202212:30 pmRNSHolding(s) in Company
8th Mar 20227:03 amRNSPublication: Nanopore IDs >50 genetic diseases
1st Mar 20225:00 pmRNSIssue of Equity and Total Voting Rights
24th Feb 20227:00 amRNSNotice of Results
11th Feb 20225:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Feb 20225:00 pmRNSIssue of Equity and Total Voting Rights
24th Jan 20223:00 pmRNSAppointment of Senior Independent Director
18th Jan 20221:00 pmRNSHolding(s) in Company
13th Jan 20227:00 amRNSFastest human genome sequence uses Oxford Nanopore
11th Jan 20226:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
7th Jan 202212:00 pmRNSUpdate to FY21 revenue guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.